Juno Therapeutics Inc
JUNO · Chemicals & Drugs · NASDAQ · in our data December 19, 2014 to March 5, 2018 (3.2 years)
The first trading day in our data for Juno Therapeutics Inc is December 19, 2014 (its first day in our records, which may be later than its listing and is not its founding). At its peak, on March 5, 2018, the market valued it at $10.1 billion. It left the market when it was bought or merged, last trading at $86.96, 0.0% from its split-adjusted high. Holders got whatever the deal paid, which is not in our price data.
Share prices are adjusted for splits and other share changes, so the high and the last price compare like for like; the peak market value is as it was on the day. The return covers the trading days in our data only: it does not include what holders received, or lost, after the last trade (a merger payout, a bankruptcy), and it does not reach back before 2014.
Play today's Daily DropAlso gone in 2018: Chemicals & Drugs
- Praxair, Inc. peaked at $48.6 billion
- Bioverativ Inc peaked at $11.4 billion
- Avexis Inc peaked at $8.0 billion
- Foundation Medicine Inc peaked at $5.1 billion
- Endocyte Inc peaked at $2.0 billion
- Ignyta Inc peaked at $1.8 billion
